Topical drug delivery market seen reaching $308.14B by 2030

The topical drug delivery market is projected to grow from $198.71 billion in 2026 to $308.14 billion by 2030, according to a new report from The Business Research Company. Demand is being driven by rising diabetes cases, broader use of skin-applied therapies and growing interest in targeted, less invasive treatments.

Why it matters: - The topical drug delivery market is expanding as healthcare systems and patients look for treatments that can target specific areas of the body with less systemic exposure. - Strong growth in the category points to rising demand for transdermal systems, semi-solid formulations and combination products across chronic and localized conditions.

What happened: - The Business Research Company released its topical drug delivery market report covering market size, trends and a global forecast for 2026-2035. - The market was valued at $177.82 billion in 2025 and is projected to reach $198.71 billion in 2026. - The report forecasts the market will rise to $308.14 billion by 2030, implying an 11.6% CAGR. - North America held the largest share of the global market in 2025. - Asia-Pacific is expected to be the fastest-growing region during the forecast period. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - A free sample of the report is available here. - The full report is available here.

The details: - Topical drug delivery uses products applied directly to the skin to deliver medication to localized areas. - The approach is used to treat a range of conditions while limiting systemic side effects. - The report links near-term growth to the increasing prevalence of skin disorders, greater use of topical treatments for chronic diseases, expanded pharmaceutical production capacity, patient preference for less invasive therapies and a wider range of formulation options. - Future growth is expected to be supported by investments in advanced transdermal technologies, demand for targeted delivery methods, broader home healthcare adoption, improved drug bioavailability and development of combination topical products. - Key trends include greater use of transdermal drug delivery systems, semi-solid formulations, microneedle technology, controlled-release topical products and patient-centered drug administration. - The report also adds market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, and updated graphics and tables.

Between the lines: - Diabetes is a major demand driver because topical delivery can support medication absorption through the skin while reducing systemic side effects. - The report cites International Diabetes Federation data showing about 589 million adults ages 20-79 were living with diabetes worldwide in April 2025. - The same data set includes more than 9.5 million people with type 1 diabetes, including 1.9 million children and adolescents under 20. - Diabetes cases are projected to reach 853 million by 2050. - More than 3.4 million adults ages 20-79 died from diabetes-related causes in 2024. - The regional split suggests mature markets are still driving scale, while faster adoption in Asia-Pacific could reshape the growth mix over the next few years.

What's next: - The market is expected to keep climbing through 2030 as transdermal delivery, controlled-release formats and home-based care become more common. - The Business Research Company says report updates will continue to emphasize forecasting tools, trend analysis and market segmentation for buyers tracking the sector. - More information is available through the company’s LinkedIn page.